Similar articles

• Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.

  Poppema S, Timens W, Visser L. Poppema S, et al. Adv Exp Med Biol. 1985;186:963-9. doi: 10.1007/978-1-4613-2463-8_116. Adv Exp Med Biol. 1985. PMID: 2931963 No abstract available.
• Cell surface markers in leukemia: biological and clinical correlations.

  Thiel E. Thiel E. Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2. Crit Rev Oncol Hematol. 1985. PMID: 3013441 Review.
• Surface markers on leukemia and lymphoma cells: recent advances.

  Foon KA, Schroff RW, Gale RP. Foon KA, et al. Blood. 1982 Jul;60(1):1-19. Blood. 1982. PMID: 6805534 Review. No abstract available.
• The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.

  Habeshaw JA, Bailey D, Stansfeld AG, Greaves MF. Habeshaw JA, et al. Br J Cancer. 1983 Mar;47(3):327-51. doi: 10.1038/bjc.1983.52. Br J Cancer. 1983. PMID: 6338896 Free PMC article.
• Malignant lymphomas as tumours of the immune system.

  Berard CW, Cossman J, Jaffe ES. Berard CW, et al. Br J Cancer. 1980 Jul;42(1):1-20. doi: 10.1038/bjc.1980.197. Br J Cancer. 1980. PMID: 7000112 Free PMC article. Review.